Report Overview
Visitedpublic
2025-08-13 17:39:36
Tags
Submit Tags
URL
ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-reports-ser-155-phase-1b-placebo-controlled
Finishing URL
ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-reports-ser-155-phase-1b-placebo-controlled
IP / ASN
23.36.77.170
#20940 Akamai International B.V.
Title
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) | Seres Therapeutics

Detections

urlquery
0
Network Intrusion Detection
3
Threat Detection Systems
0

Host Summary

HostRankRegisteredFirst SeenLast Seen
analytics.imirwin.com
7978422018-03-162022-10-282025-08-12
ir.serestherapeutics.com
unknown2011-06-032015-06-292023-09-17
ml.globenewswire.com
4515642007-09-082019-03-102025-08-08
assets.adobedtm.com
30512013-11-222014-01-282025-08-06
use.typekit.net
40542010-08-022012-07-052025-08-06
www.globenewswire.com
915032007-09-082012-09-262025-08-08
p.typekit.net
46382010-08-022012-05-232025-08-06

Related reports

Network Intrusion Detection Systems

Suricata /w Emerging Threats Pro

SeveritySource IPDestination IPAlert
medium
172.18.0.17
192.169.69.26
ET INFO DYNAMIC_DNS HTTP Request to a *.duckdns .org Domain
medium
172.18.0.17
192.169.69.26
ET INFO DYNAMIC_DNS HTTP Request to a *.duckdns .org Domain
medium
172.18.0.17
192.169.69.26
ET INFO DYNAMIC_DNS HTTP Request to a *.duckdns .org Domain
Threat Detection Systems
No alerts detected

JavaScript (16)

HTTP Transactions (40)

URLIPResponseSize